DOJ Offers Drugmakers ‘Get out of FCA Litigation Free’ Card

Drug Industry Daily
The Department of Justice is offering drug companies on the receiving end of False Claims Act litigation a chance to walk away without crippling fines—as long as they disclose the fraud, cooperate with investigators and fix any underlying problems.

To View This Article:


Subscribe To Drug Industry Daily